3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
17
Terminated
6
Unknown
4
Recruiting
4
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
101
Squamous Cell Carcinoma of Head and Neck
76
Oropharyngeal Neoplasms
19
Carcinoma, Squamous Cell
16
Thyroid Neoplasms
15
Carcinoma, Non-Small-Cell Lung
12
Breast Neoplasms
11
Carcinoma
10
Neoplasms
9
Mouth Neoplasms
9
Lung Neoplasms
9
Laryngeal Neoplasms
9
Tongue Neoplasms
8
Stomach Neoplasms
7
Salivary Gland Neoplasms
7
Neoplasm Metastasis
7
Prostatic Neoplasms
6
Ovarian Neoplasms
6
Nasopharyngeal Carcinoma
6
Hypopharyngeal Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Thyroid Carcinoma, Anaplastic
5
Small Cell Lung Carcinoma
5
Melanoma
5
Esophageal Neoplasms
5
Pancreatic Neoplasms
4
Mucositis
4
Carcinoma, Renal Cell
4
Xerostomia
3
Interventions
zimberelimab
1
Radiation
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Pharyngeal Neoplasms
×
Head & Neck
×
Clear all
NCT04892875
2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1
Withdrawn